[ad_1] NEW YORK, Nov. 2, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Xiao-I Corporation (“Xiao-I” or the “Company”) (NASDAQ: AIXI) and certain officers and directors. The class […]
Tag: Pomerantz LLP
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc.
[ad_1] NEW YORK, Nov. 2, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Novavax, Inc. (“Novavax” or the “Company”) (NASDAQ: NVAX). Such investors are advised to contact Danielle Peyton at [email protected] or […]
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Agenus Inc. of Class Action Lawsuit and Upcoming Deadlines
[ad_1] NEW YORK, Nov. 2, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Agenus Inc. (“Agenus” or the “Company”) (NASDAQ: AGEN) and certain officers. The class action, filed in […]
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sun Communities, Inc.
[ad_1] NEW YORK, Nov. 2, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sun Communities, Inc. (“Sun” or the “Company”) (NYSE: SUI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, […]
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allarity Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines
[ad_1] NEW YORK, Nov. 2, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR) and certain officers. The class action, filed […]
